Peptide injection site reaction: red, itchy or a lump. When to worry

Trouble breathing or a swollen face? Call 911.

Those can be signs of a severe allergic reaction. Do not wait.

By the Peptide Science Desk Editorial TeamFact-checked against FDA and official sources · Oct 28, 2026Not yet reviewed by a licensed clinician. How we check facts

Short answer: Mild redness, itching, a small bruise or soreness where you injected is a known side effect of GLP-1 shots like Wegovy and Zepbound. In Zepbound trials it happened to 6% to 8% of people, vs 2% on placebo. Most of it is mild. Get help fast if redness spreads or grows, the area gets hot or leaks pus, you get a fever, or you have trouble breathing or a swollen face. Peptides bought online, like BPC-157, have no safety testing, so any reaction is a bigger unknown.

Two scientists in lab coats look closely at a small glass vial — Two scientists check a vial in a National Cancer Institute lab (2000 photo).Photo: Bill Branson, National Cancer Institute (NIH), public domain

Is it normal to have a red itchy bump after a peptide injection?

A small red, itchy or sore spot is a known side effect of GLP-1 shots.
The FDA label for Zepbound counts bruising, redness, itching, pain and rash where you injected as "injection site reactions."
Placebo shots cause them too, because a needle alone can bother skin.
Normal does not mean ignore it. Tell your doctor about any reaction, even a small one.

How common are injection site reactions on Zepbound and Wegovy?

Zepbound (tirzepatide): 6% at the lowest strength studied and 8% at higher ones, vs 2% on placebo.
Wegovy (semaglutide) shots: 1.4% vs 1% on placebo in weight-loss trials.
In Zepbound trials, people whose body made antibodies to the drug had reactions more often: 11.3% vs 1% of people who did not.
See the chart below.

Why do I have a lump at my injection site?

The Zepbound instructions say shots can cause two kinds of skin change where you inject: pits or thick skin (lipodystrophy), and lumps (localized cutaneous amyloidosis).
The instructions say not to inject into skin that has pits, is thick, has lumps, or is tender, bruised, scaly or hard, or into scars.
The FDA labels for Wegovy and Zepbound both say to change (rotate) the spot each time.
A lump that is hot, growing or painful is different. That can be infection. See the warning signs below.

Zepbound FDA label and instructions

When is an injection site reaction an emergency?

Call 911 if you have trouble breathing, wheezing, swelling of the face, eyes or tongue, or you feel faint. Those are signs of anaphylaxis, a severe allergic reaction, says NIH's MedlinePlus.
The Wegovy and Zepbound labels say serious allergic reactions have been reported. They tell patients to stop the drug and get medical help right away if this happens.

How do I know if my injection site is infected?

MedlinePlus lists these signs of cellulitis, a skin infection: redness that gets bigger, warm skin, pain, swelling, a tight shiny look, fever or chills.
Red streaks spreading from the spot, or pus, are also warning signs.
Call your doctor right away if you see these. MedlinePlus says cellulitis is usually treated with antibiotics.

Are peptides bought online more likely to cause reactions?

Nobody has measured it. Peptides like BPC-157, TB-500 and GHK-Cu sold as "research only" are not FDA approved, so no trial counted their skin reactions.
For several peptides on its risk list, the FDA says it has limited safety information and that they may cause immune reactions (immunogenicity).
Vials from unregulated sellers are not checked for germs or other contamination. That is a real risk with anything injected.
If you used a peptide bought online and get a reaction, tell your doctor exactly what it was and where it came from.
For compounded GLP-1 shots, a 2026 study of FDA reports found more reports of germs in the drug (contamination) than for brand drugs. Reports cannot prove cause.

How often do GLP-1 shots cause injection site reactions?

% of people with a reaction where they injected (redness, itching, pain, bruising, rash), from FDA labels

GLP-1: Wegovy shotsemaglutide, weight-loss trials

1.4%

1.0%

GLP-1: Zepbound, lowest strength studiedtirzepatide 5 mg

6.0%

2.0%

GLP-1: Zepbound, higher strengthstirzepatide 10 mg and 15 mg

8.0%

2.0%

Zepbound users who made antibodiesimmune proteins against the drug

11.3%

1.0%

Last row: in Zepbound trials, reactions happened in 11.3% of people who made antibodies to the drug vs 1% of those who did not (the gray bar here means "no antibodies", not placebo).

Show the numbers as a table

How often do GLP-1 shots cause injection site reactions?: % of people with a reaction where they injected (redness, itching, pain, bruising, rash), from FDA labels
Group (FDA label)	On the drug	On placebo
GLP-1: Wegovy shot semaglutide, weight-loss trials	1.4%	1.0%
GLP-1: Zepbound, lowest strength studied tirzepatide 5 mg	6.0%	2.0%
GLP-1: Zepbound, higher strengths tirzepatide 10 mg and 15 mg	8.0%	2.0%
Zepbound users who made antibodies immune proteins against the drug	11.3%	1.0%

Placebo shots cause reactions too, because a needle alone can irritate skin. Peptides sold online, like BPC-157, have no trials big enough to count this. Sources: Wegovy (semaglutide) tablets and injection, FDA label (June 2026); Zepbound (tirzepatide), FDA label (Aug 2026).

More charts: Peptides by the numbers

Where these numbers come from

These are the FDA labels for approved GLP-1 shots. Peptides sold online have no studies like these.

Study type	People	Main finding	Limits
Zepbound weight-loss trials (FDA label)	Thousands of adults	Injection site reactions: 6% to 8% vs 2% on placebo	Trials last up to 72 weeks
Wegovy weight-loss trials (FDA label)	Adults in weight-loss trials	Injection site reactions: 1.4% vs 1% on placebo	Pooled trial data
Zepbound antibody data (FDA label)	Pool of 2 trials	Reactions: 11.3% with antibodies vs 1% without	Not a separate trial
Review of 19 trials, tirzepatide vs other GLP-1 drugs	13,529 people	Tirzepatide (10 or 15 mg) had more injection site reactions than GLP-1-only drugs	Trials were not built to compare skin reactions
FDA reports, compounded vs brand GLP-1	81,078 reports (707 compounded)	More reports of contamination with compounded shots	Reports cannot prove cause

Injection site: what you see and what to do

	What it may be	What to do
Small red, itchy or sore spot	A common, mild reaction	Tell your doctor at your next visit, or sooner if it worries you
Bruise	Common with any shot	Tell your doctor if it is large or keeps happening
Pits, thick skin or a lump that is not hot	Skin change from repeated shots in one spot	Do not inject there. Ask your doctor
Redness that spreads, warm skin, pus, fever	Possible infection (cellulitis)	Call your doctor right away
Trouble breathing, swollen face or tongue, feeling faint	Possible severe allergic reaction	Call 911 now

Check any peptide in 1 secondFree FDA Status Checker: approved, being tested, or not proven.

FAQ

How long does an injection site reaction last?

The labels do not give a time. Mild spots often fade, but if one grows, gets hot or does not go away, call your doctor.

Can I put ice or cream on it?

Ask your doctor or pharmacist what is right for you. We do not give treatment advice.

Why does it itch where I inject?

Itching is one of the reactions the Zepbound label lists. It can also be an allergic sign, so tell your doctor, especially if you also get hives.

Should I stop my shot if I get a reaction?

Do not stop or change a medicine on your own. Call your doctor. For trouble breathing or face swelling, call 911.

Is a lump at the injection site cancer?

The labels describe lumps from skin changes and from injecting in the same spot. Any lump that grows or worries you should be checked by a doctor.

We never share doses or tell you where to buy. Always ask your doctor. Print our doctor questions sheet.

Sources

Not medical advice. Medical disclaimer.